Brian Alexander: Excited about our new collaboration with Gustave Roussy and Roche France to bring liquid biopsy genomic testing to patients in France.

Brian Alexander, CEO of Foundation Medicine, shared on LinkedIn:

“Excited about our new collaboration with Gustave Roussy and Roche France to bring liquid biopsy genomic testing to patients in France.
Cancer is a disease of the genome and it’s critical that physicians have access to high-quality, well-validated genomic tests to inform treatment options for their patients.”

For details click here.
Source: Brian Alexander/LinkedIn